Corporate Website
Africa
Argentina
Asia
Australia
Belgium
Brazil
Bulgaria
Canada (EN)
Chile
China
Colombia
Denmark
Egypt
France
Germany
Greece
Hungary
Indonesia
Italia
India
Japan
Korea
Malaysia
Mexico
Middle East
Netherlands
Peru
Philippines
Poland
Portugal
Romania
Russia
South Africa
Spain
Sweden
Thailand
Tunisia
Turkey
Ukraine
United Kingdom
USA
Vietnam
Your search for "innovation" return 116 results.
Signature of a scientific collaboration protocol about avian influenza with South China Agricultural University >
Paris, May 29th 2013 1- Ceva, a socially responsible company committed to the well-being of the planet Ceva Santé Animale is a multi-national French based animal health company that counts over 3000 e...
Ceva uses creative thinking in new approach to innovation in Industrial equity >
Libourne, France 2nd May 2013: Most of the time innovation in the bio-pharmaceutical field is associated with the scientific R&D teams. But having the latest technology vaccines is of little value i...
Ceva creates 60 strong teams to support innovative vaccination services on farm and in the hatchery >
Recent research showed Ceva that their customers want more than just good vaccines; they want 100% of their birds correctly vaccinated.
New Technology Vaccine Symposium - Miami >
Ceva shares global field experiences through New Technology Vaccine Symposium held in the US. Innovation in the hatchery will drive productivity gains
Hatchery vaccination services >
The best vaccines can only work if they are administered properly, inside the bird or the egg, in the right place, at the right dose and in a clean environment.
Ceva records double digit growth for 3rd. successive year >
14% growth pushes sales beyond 600 M€ for first time
Ceva presents a complete range of vector vaccines at IPE 2013 >
Vectormune® ND and Transmune® IBD, “The Perfect Pair” of vaccines for Gumboro and Newcastle prevention can now be administered in one injection at the hatchery.
Ceva announces scientific breakthrough with the launch of Vectormune® AI >
Vectormune® AI a new generation vaccine for the control of Avian Influenza.
AXA Private Equity provides additional financing to support the development of Ceva >
AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.
Ceva launches CARDALIS® for dogs with heart failure >
A powerful dual treatment in a single tablet